251 related articles for article (PubMed ID: 1177347)
1. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
Seah SK
J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
Nguyen BT; Stadtsbaeder S
Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
[TBL] [Abstract][Full Text] [Related]
3. [A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)].
Coradello H; Kretschmer S
Wien Klin Wochenschr; 1978 Jan; 90(1):25-9. PubMed ID: 625985
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
Xiang X; Ke OY; Zhang Z
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
[TBL] [Abstract][Full Text] [Related]
7. [Comparative Chemotherapeutical studies on the effect of Bactrim and other combined preparations on the proliferative and cystforming phase of Toxoplasma gondii in NMRI mice. A contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
Werner H; Egger I
Zentralbl Bakteriol Orig A; 1975; 231(1-3):349-64. PubMed ID: 1154912
[TBL] [Abstract][Full Text] [Related]
8. [Experimental studies on the effect of the combination sulfamoxole/trimethoprim on the Toxoplasma infection of the mouse (author's transl)].
Maier W; Piekarski G
Arzneimittelforschung; 1976; 26(42):620-2. PubMed ID: 947322
[TBL] [Abstract][Full Text] [Related]
9. [Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole].
Garin JP; Paillard B
Ann Pediatr (Paris); 1984 Nov; 31(10):841-5. PubMed ID: 6517460
[No Abstract] [Full Text] [Related]
10. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
Harper JS; London WT; Sever JL
Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of toxoplasmosis].
Terragna A; Canessa A
G Ital Chemioter; 1984; 31(1-2):7-15. PubMed ID: 6381209
[No Abstract] [Full Text] [Related]
12. The effect of some drugs on acute toxoplasmosis in mice.
Hamadto HH; Rashed SM; Marii NE; Sobhy MM; el-Ridi AM; el-Fakahany AF
J Egypt Soc Parasitol; 1989 Dec; 19(2):523-6. PubMed ID: 2788673
[TBL] [Abstract][Full Text] [Related]
13. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
Aguirre-Cruz L; Sotelo J
J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
15. Activity of the combination trimethoprim-sulfamethoxazole on experimental toxoplasmosis.
Terragna A; Rossolini A; Cellesi C; Figura N; Barberi A
Arzneimittelforschung; 1973 Sep; 23(9):1328-31. PubMed ID: 4590193
[No Abstract] [Full Text] [Related]
16. Minocycline in the chemotherapy of murine toxoplasmosis.
Tabbara KF; Sakuragi S; O'Connor GR
Parasitology; 1982 Apr; 84(Pt 2):297-302. PubMed ID: 7070843
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
[TBL] [Abstract][Full Text] [Related]
18. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
Araujo FG; Lin T; Remington JS
J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
[TBL] [Abstract][Full Text] [Related]
19. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
Aguirre-Cruz L; Velasco O; Sotelo J
J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
